Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?

Bibliographic Details
Main Authors:	Srijan Chatterjee, Manojit Bhattacharya, Kuldeep Dhama, Sang-Soo Lee, Chiranjib Chakraborty
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Molecular Therapy: Nucleic Acids
Subjects:	significant mutation nirmatrelvir Mpro Omicron subvariant SARS-CoV-2
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253123000720

Internet